Skip to content

Application of auricular point staging method combined with traditional Chinese medicine in Artificial insemination by husband

Application of auricular point staging method combined with traditional Chinese medicine in Artificial insemination by husband

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005745
Enrollment
Unknown
Registered
2022-03-21
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

stimutating ovulation cycle group (combined treatment group):Application of auricular point staging method combined with traditional Chinese medicine
Natural Cycle Group (Chinese Medicine Group):traditional Chinese medicine staging method
Natural cycle group (combined treatment group):Application of auricular point staging method combined with traditional Chinese medicine
stimutating ovulation cycle group (Chinese medicine group):traditional Chinese medicine staging method

Sponsors

Dongfang Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1)meet AIH's admission criteria; (2) 20-40 years old; (3) meet TCM diagnosis of kidney qi deficiency; (4)no significant abnormalities were found after routine gynecological examination, fallopian tube and female endocrine examination, or Normalized after treatment. The above four criteria must be met simultaneously.

Exclusion criteria

Exclusion criteria: (1)female with systemic diseases or reproductive organ abnormality;(2)one spouse with serious primary diseases such as cardiovascular, cerebrovascular, hepatic, renal, hematopoietic and endocrine system;(3)one spouse with serious genetic disease, physical illness or psychosomatic disorder;(4)one spouse with cute infections of the genitourinary system or sexually transmitted diseases;(5) one spouse is in a role period contacted teratogenic amount of radiation, toxins, drugs; (6)female who are allergic to multiple drugs, gumbo or the components of the herbal medicine used.(7)female who have participated in other clinical studies within the last month.Meet one of the above was not allowed to join in.

Design outcomes

Primary

MeasureTime frame
clinial pregnancy outcome;

Secondary

MeasureTime frame
endometrial receptivity;psychological states;

Countries

China

Contacts

Public ContactYu yanyan
249214223@qq.com13466316616

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026